With 58% institutional ownership, Animalcare Group plc (LON:ANCR) is a favorite amongst the big guns

Key Insights Given the large stake in the stock by institutions, Animalcare Group's stock price might be vulnerable ...

ENHERTU® (fam-trastuzumab deruxtecan-nxki) plus pertuzumab approved in the US as first new treatment in a decade for the 1st-line treatment of patients with HER2-positive ...

AstraZeneca and Daiichi Sankyo’s ENHERTU® (fam-trastuzumab deruxtecan-nxki) in combination with pertuzumab has been approved in the US for the 1st-line treatment of adult patients with unresectable or ...